Sartorius Stedim Biotech SA 2009 IR
The report outlines the financial and operational performance of Sartorius Stedim Biotech Group for the fiscal year 2009. The company achieved significant growth, with sales revenue increasing by 8.0% in constant currencies to ‐401.2 million, driven by strong demand for single-use biomanufacturing products. Operating profit (EBITA) rose by 50.5% to ‐60.3 million, reflecting an improved product mix and efficient cost management. Key developments included the launch of the FlexAct product line and the inauguration of a new manufacturing facility in Bangalore, India. Additionally, the company made progress in environmental management, reducing carbon dioxide emissions at its Goettingen site and recycling approximately 80% of production waste at its French and Tunisian facilities.
Company: Sartorius Stedim Biotech SA
Sector: Manufacturing
Country: France
Year: 2009
Type: IR
Pages: 181
Back to company
Sartorius Stedim Biotech SA
Reference Document
The report outlines the financial and operational performance of Sartorius Stedim Biotech Group for the fiscal year 2009. The company achieved significant growth, with sales revenue increasing by 8.0% in constant currencies to ‐401.2 million, driven by strong demand for single-use biomanufacturing products. Operating profit (EBITA) rose by 50.5% to ‐60.3 million, reflecting an improved product mix and efficient cost management. Key developments included the launch of the FlexAct product line and the inauguration of a new manufacturing facility in Bangalore, India. Additionally, the company made progress in environmental management, reducing carbon dioxide emissions at its Goettingen site and recycling approximately 80% of production waste at its French and Tunisian facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2009
Reporting Period
Jan 1, 2009 - Dec 31, 2009
Fiscal Year
2009
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees